Sutro Biopharma Inc is a biotechnology company that focuses on the development of innovative therapeutics using its proprietary cell-free protein synthesis platform. The company specializes in creating a new class of proteins, including antibody-drug conjugates and other biopharmaceuticals, which are designed to treat various types of cancer and other serious illnesses. Sutro's approach allows for the precise and efficient production of complex proteins, enabling the exploration of novel medicines that can more effectively target disease pathways. Through its research and development efforts, the company aims to improve patient outcomes and address unmet medical needs. Read More
What has Wall Street been buzzing about this week? Here is a look at the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of March 10-14, 2025.
Stay up-to-date with the latest market trends one hour before the close of the markets on Friday. Explore the top gainers and losers during today's session in our detailed report.
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Shares of Kodiak Sciences Inc. (NASDAQ: KOD) fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 per share, compared to market expectations for a loss of 77 cents per share.
U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat quarterly earnings.
